CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 4 Planned sale PRESIDENT AND CEO sold 47,709 shares at $25.04 ($1,194,700)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 14,000 shares at an average $24.72 ($346,149)
- 4 Planned sale Director sold 6,964 shares at an average $24.11 ($167,888)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 20,000 shares at $25.07 ($501,478)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Planned sale Director sold 67,000 shares at an average $23.36 ($1,564,812)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale CHIEF OPERATING OFFICER sold 4,875 shares at an average $18.60 ($90,687)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
Page 21 of 40 · 798 filings